XNCR
Xencor Inc
NASDAQ: XNCR · HEALTHCARE · BIOTECHNOLOGY
$11.93
+2.67% today
Updated 2026-04-30
Market cap
$861.36M
P/E ratio
—
P/S ratio
6.86x
EPS (TTM)
$-1.24
Dividend yield
—
52W range
$7 – $19
Volume
0.9M
Xencor Inc (XNCR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.85M | $9.52M | $10.17M | $9.52M | $27.76M | $87.52M | $35.71M | $40.60M | $156.70M | $122.69M | $275.11M | $164.58M | $168.34M | $110.49M | $125.58M |
| Revenue growth (YoY) | — | +39.1% | +6.8% | -6.4% | +191.6% | +215.3% | -59.2% | +13.7% | +285.9% | -21.7% | +124.2% | -40.2% | +2.3% | -34.4% | +13.7% |
| Cost of revenue | — | $12.67M | $17.00M | $18.52M | $34.14M | $51.87M | $71.77M | $97.50M | $118.59M | $169.80M | $7.49M | $8.80M | $253.60M | $12.11M | $10.51M |
| Gross profit | $6.85M | $-3.14M | $-6.83M | $-9.00M | $27.76M | $87.52M | $35.71M | $40.60M | $38.11M | $122.69M | $275.11M | $164.58M | $-85.26M | $110.49M | $115.06M |
| Gross margin | 100.0% | -33.0% | -67.1% | -94.5% | 100.0% | 100.0% | 100.0% | 100.0% | 24.3% | 100.0% | 100.0% | 100.0% | -50.6% | 100.0% | 91.6% |
| R&D | $12.66M | $12.67M | $17.00M | $18.52M | $34.14M | $51.87M | $71.77M | $97.50M | $118.59M | $169.80M | $192.51M | $199.56M | $253.60M | $227.69M | $239.43M |
| SG&A | $3.64M | $3.09M | $3.69M | $7.46M | $11.96M | $13.11M | $17.50M | $22.47M | $24.29M | $29.69M | $38.84M | $47.49M | $53.38M | $61.22M | $63.64M |
| Operating income | $-9.45M | $-6.23M | $-10.52M | $-16.46M | $-18.34M | $22.54M | $-53.56M | $-79.37M | $13.82M | $-76.80M | $43.77M | $-82.47M | $-138.64M | $-178.41M | $-177.50M |
| Operating margin | -138.0% | -65.4% | -103.4% | -172.9% | -66.1% | 25.8% | -150.0% | -195.5% | 8.8% | -62.6% | 15.9% | -50.1% | -82.4% | -161.5% | -141.4% |
| EBITDA | $-8.75M | $-5.61M | $-58.34M | $-15.53M | $-17.23M | $24.01M | $-51.53M | $-76.12M | $18.12M | $-71.00M | $51.26M | $-73.67M | $-125.87M | $-186.17M | $-46.98M |
| EBITDA margin | -127.7% | -58.9% | -573.5% | -163.1% | -62.0% | 27.4% | -144.3% | -187.5% | 11.6% | -57.9% | 18.6% | -44.8% | -74.8% | -168.5% | -37.4% |
| EBIT | $-9.35M | $-6.13M | $-59.05M | $-16.41M | $-18.34M | $22.54M | $-53.56M | $-79.37M | $13.82M | $-76.80M | $43.77M | $-82.47M | $-137.37M | $-198.28M | $-57.49M |
| Interest expense | $1.85M | $2.46M | $1.21M | $9000.00 | $13000.00 | $21000.00 | $13000.00 | $16000.00 | $17.66M | $0.00 | $7.49M | $36.76M | $6.18M | $36.64M | $31.93M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-11.20M | $-8.59M | $-60.26M | $-16.42M | $-17.59M | $23.63M | $-48.92M | $-70.41M | $26.88M | $-63.54M | $82.63M | $-55.18M | $-126.09M | $-232.62M | $-91.92M |
| Net income growth (YoY) | — | +23.3% | -601.2% | +72.7% | -7.1% | +234.3% | -307.1% | -43.9% | +138.2% | -336.4% | +230.0% | -166.8% | -128.5% | -84.5% | +60.5% |
| Profit margin | -163.6% | -90.2% | -592.4% | -172.5% | -63.4% | 27.0% | -137.0% | -173.4% | 17.2% | -51.8% | 30.0% | -33.5% | -74.9% | -210.5% | -73.2% |